Elicio Therapeutics ELTX
NASDAQ ELTX
$1.92 -0.02 (-1.03%)
As of: Oct 23, 2026 · 1:35 PM EDT

Elicio Therapeutics (ELTX) Cash & Equivalents (2020 - 2026)

Updated

Elicio Therapeutics (ELTX) reported Cash & Equivalents of $23.5 million for Q2 2026, up 6.4% from $22.09 million a year earlier and up 57.2% from the prior quarter.

Analysis

Elicio Therapeutics (ELTX) Cash & Equivalents (2020 - 2026) Analysis & Trends

At the end of FY2025, Elicio Therapeutics posted Cash & Equivalents of $18.56 million, up 5.4% from FY2024.

  • Cash & Equivalents has increased for three consecutive years, though with a five-year compound annual growth rate of -11.7% (FY2020 to FY2025).
  • By year, Cash & Equivalents came in at $17.62 million in FY2024 (+36.6%), $12.89 million in FY2023 (+109.5%), $6.16 million in FY2022 (-93.1%) and $88.76 million in FY2021 (+156.5%).
  • The Q2 2026 figure ranks as the highest quarterly Cash & Equivalents since Q3 2024.
  • Year over year, Cash & Equivalents gained in six of the last eight quarters, with growth averaging 85.5%.
  • The high point for year-over-year Cash & Equivalents in five years was Q3 2023 (growth of 707.0%); the low point was Q2 2022 (a decline of 99.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $14.95 million (Q1 2026), $18.56 million (Q4 2025) and $20.61 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,134.76 Bn 1,103.34 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 634.69 Bn 554.55 Bn 17.30 Bn 16.91 Bn
3 AbbVie 506.51 Bn 479.62 Bn 12.70 Bn 6.57 Bn
4 Merck 357.95 Bn 312.33 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 293.14 Bn 257.13 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 265.38 Bn 239.06 Bn 12.86 Bn 4.90 Bn
7 Amgen 238.37 Bn 193.77 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 195.16 Bn 169.36 Bn 6.22 Bn 3.18 Bn
9 Pfizer 170.88 Bn 117.53 Bn 10.94 Bn 976.00 Mn
10 Elicio Therapeutics 37.05 Mn -40.58 Mn - 23.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.50 Mn
Mar 31, 2026 14.95 Mn
Dec 31, 2025 18.56 Mn
Sep 30, 2025 20.61 Mn
Jun 30, 2025 22.09 Mn
Mar 31, 2025 18.35 Mn
Dec 31, 2024 17.62 Mn
Sep 30, 2024 26.02 Mn
Jun 30, 2024 3.43 Mn
Mar 31, 2024 11.85 Mn
Dec 31, 2023 12.89 Mn
Sep 30, 2023 14.84 Mn
Jun 30, 2023 21.68 Mn
Mar 31, 2023 8.57 Mn
Dec 31, 2022 6.16 Mn
Sep 30, 2022 1.84 Mn
Jun 30, 2022 598,000.00
Mar 31, 2022 73.00 Mn
Dec 31, 2021 88.76 Mn
Sep 30, 2021 102.74 Mn
API Access

Elicio Therapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ELTX&period=max&api_key=YOUR_API_KEY